NICE technology appraisal guidance
Issued: August 2005
TA93

Colorectal cancer (advanced) - irinotecan, oxaliplatin and raltitrexed (repaced by CG131) (TA93)

This is an extract from the guidance and may be misleading if read alone. The complete guidance is available at guidance.nice.org.uk/ta93

Important information about this guidance

This guidance has been updated and replaced by NICE clinical guideline 131.